EpiPen patent revoked in Europe

The European Patent Office (EPO) has revoked a patent covering Mylan’s EpiPen (epinephrine) injector after finding that patent amendments contravened the European Patent Convention (EPC).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Judge approves Pfizer’s $345m EpiPen settlement

18 November 2021 EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Americas

FDA grants Teva approval for first EpiPen generic

17 August 2018 The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

Big Pharma

EPO gears up to hear EpiPen patent opposition

27 February 2018 The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.

More on this story

Americas

Judge approves Pfizer’s $345m EpiPen settlement

18 November 2021 EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Americas

FDA grants Teva approval for first EpiPen generic

17 August 2018 The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

Big Pharma

EPO gears up to hear EpiPen patent opposition

27 February 2018 The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.

More on this story

Americas

Judge approves Pfizer’s $345m EpiPen settlement

18 November 2021 EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Americas

FDA grants Teva approval for first EpiPen generic

17 August 2018 The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

Big Pharma

EPO gears up to hear EpiPen patent opposition

27 February 2018 The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.